Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00005485 · ClinicalTrials.gov registry record
The Jackson Heart Study of Cardiovascular Disease Among African Americans
A clinical trial of Hypertension and Cardiovascular Diseases, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- Active
- Registry status
- 5,306
- Enrollment target
- 1
- Study location
NCT00005485: Active study of Hypertension and Cardiovascular Diseases, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
NCT00005485 is a study of Hypertension and Cardiovascular Diseases that is active but no longer recruiting, run by National Heart, Lung, and Blood Institute (NHLBI). The registered enrollment target is 5,306 participants, above the 3,496-participant average among 470 other Hypertension trials with a reported enrollment target (52% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00005485, a study of Hypertension and Cardiovascular Diseases, is active but no longer recruiting, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- ACTIVE NOT RECRUITING
- Registry status
- 5,306 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective study of the environmental and genetic factors that influence the development of cardiovascular disease (CVD) in African American adults. The cohort is a collaboration among multiple institutions (Jackson State University, Mississippi State Department of Health, Tougaloo College, and the University of Mississippi Medical Center), NIMHD, and NHLBI.
Primary Outcome
Coronary Heart Disease, Stroke, Heart Failure
Conditions Studied
Study Locations (1)
Mississippi
- UMMC, JSU, Tougaloo College, MSDH - Jackson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,306 participants |
| Start Date | 2000-09-19 |
| Est. Completion | 2025-08-12 |
What the registry record for NCT00005485 still lists
NCT00005485 is an observational study that tracks outcomes without assigning an intervention. Its 5,306 participants enrollment target places it among the larger protocols in the corpus, above the 3,496-participant average among 470 other Hypertension trials with a reported enrollment target (52% higher).
The record links to 6 conditions, with Hypertension appearing as the primary indexed condition, and to 0 interventions.
NCT00005485 reports a single indexed study location in Mississippi.
Frequently Asked Questions
What is clinical trial NCT00005485 about?
NCT00005485 is a clinical study titled "The Jackson Heart Study of Cardiovascular Disease Among African Americans". This is a prospective study of the environmental and genetic factors that influence the development of cardiovascular disease (CVD) in African American adults. The cohort is a collaboration among multiple institutions (Jackson State University, Mississippi State Department of Health, Tougaloo Colleg...
What is the current status of trial NCT00005485?
This trial is currently active not recruiting. The enrollment target is 5,306 participants. The study started on 2000-09-19. Estimated completion is 2025-08-12.
What conditions does trial NCT00005485 study?
This clinical trial studies the following conditions: Hypertension, Cardiovascular Diseases, Heart Diseases, Atherosclerosis, Coronary Disease.
Who is sponsoring clinical trial NCT00005485?
This trial is sponsored by National Heart, Lung, and Blood Institute (NHLBI), which has 501 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00005485 being conducted?
This trial has 1 study location across Mississippi. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00005485's enrollment target sits among peer trials
5,306 28th of 470 higher than 443 of 470 other Hypertension trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
How a Mediterranean Diet With Potatoes Impacts Heart and Metabolic Health in Adults With Pre-Diabetes
RECRUITING · NA
-
Autonomic Regulation of Blood Pressure in Premature and Early Menopausal Women
RECRUITING
-
Conical Forearm and Cylindrical Upper Arm Non-Invasive Blood Pressure (NIBP) Measurements in Pregnant Patients
RECRUITING · NA
-
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
RECRUITING · NA
-
Childhood-Onset Essential Hypertension Natural History Study
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05373771 · 5,328 participants · NA
Sickle Cell Improvement: Enhancing Care in the Emergency Department
- NCT05836987 · 5,350 participants · Phase 3
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation
- NCT06506344 · 5,250 participants · NA
Syncing Screening and Services for Suicide Prevention Across Health and Justice Systems
- NCT05722769 · 5,408 participants · NA
CSTOP Now! Child Sex Trafficking Stops With You
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI